Skip to main content
. 2016 Apr 15;3(1):e000405. doi: 10.1136/openhrt-2016-000405

Table 2.

Procedural variables for patients with STEMI treated with primary PCI who died or survived during a mean follow-up of 3.5 years

Total cohort N=1313 Survived during follow-up n=1132 Died during follow-up n=181 p Value
Radial access 111 (8.5%) 107 (9.5%) 4 (2.2%) 0.0002
Mean contrast volume 146.3 146.1±51.6 148.0±49.9 0.669
STB* time (minutes) 198 (140–345) 195 (139–330) 236 (150–456) 0.01
STB time >360 min 239 (23.8%) 190 (22.1%) 49 (34.3%) 0.0022
Prasugrel used 243 (18.7%) 227 (20.1%) 16 (9.2%) 0.0002
Glycoprotein IIb-IIIa used 597 (50.9%) 516 (50.6%) 81 (52.3%) 0.71
Estimated GFR† 74.1 76.8±15.8 56.7±22.6 <0.0001
Estimated GFR <60 256 (19.6%) 157 (13.9%) 99 (55.9%) <0.0001
Procedural success 1272 (98.2%) 1108 (98.8%) 164 (94.8%) 0.0018
Cardiogenic shock 92 (7.0%) 38 (3.4%) 54 (29.8%) <0.0001
Cardiac arrest 25 (1.9%) 15 (1.3%) 10 (5.7%) 0.0009
3-vessel disease 242 (18.8%) 191 (17.2%) 51 (29.3%) 0.0003
Culprit artery
 Left main 4 (0.3%) 1 (0.1%) 3 (1.7%) 0.0088
 LAD‡ 559 (42.7%) 474 (41.9%) 85 (48.0%) 0.125
 RCA§ 525 (40.1%) 470 (41.5%) 55 (31.1%) 0.0075
 LCx¶ 204 (15.6%) 175 (15.5%) 29 (16.4%) 0.75
 Graft 17 (1.3%) 12 (1.1%) 5 (2.8%) 0.0676
>1 vessel treated 90 (7.0%) 71 (6.3%) 19 (10.9%) 0.038
Initial TIMI** flow 0–1 742 (57.7%) 632 (56.9%) 110 (63.2%) 0.114
Final TIMI flow <3 99 (7.7%) 72 (6.5%) 27 (15.7%) 0.0001
>1 stent implanted 328 (26.7%) 284 (26.5%) 44 (27.9%) 0.73
Drug-eluting stent 295 (23.0%) 274 (24.7%) 21 (12.0%) 0.0001
Mean stent diameter 3.23 3.26±1.5 3.06±0.42 0.11
Stent length 17.3 17.4±5.3 17.1±5.2 0.62

*Symptom-to-balloon time.

†Glomerular filtration rate.

‡Left anterior descending artery.

§Right coronary artery.

¶Left circumflex artery.

**Thrombolysis In Myocardial Infarction flow score.

PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction.